J Korean Neurol Assoc.
2011 Aug;29(3):224-226.
Intrathecal Chemotherapy Related Myelopathy Improved With Folate and Cyanocobalamin
- Affiliations
-
- 1Department of Neurology, Seoul National University College of Medicine, Seoul, Korea. jjsaint@snu.ac.kr
Abstract
- Intrathecal chemotherapy with methotrexate and cytarabine arabinoside is used for the treatment and prophylaxis of malignancies, but can induce myelopathy. We report the case of a 50-year-old woman with stomach cancer who developed myelopathy after administration of intrathecal cytarabine arabinoside and methotrexate. The patient's neurologic status improved rapidly after the administration of folinate (15 mg) four times daily and cyanocobalamin (100 mug) once daily. The folate metabolites may be effective in the management of intrathecal-chemotherapy-induced myelopathy.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Efficacy of Ferritin - folate - cyanocobalamin Supplementation during Pregnancy for Prevention of Anemia
- A Case of Myelopathy after Intrathecal Injection of Fluorescein
- Effects of cyanocobalamin and its combination with morphine on neuropathic rats and the relationship between these effects and thrombospondin-4 expression
- Blood Folate Level Determined by a Microplate Reader and Folate Intake Measured by a Weighted Food Record
- Serum Folate Concentrations in Psychiatric Inpatients: A Preliminary Study
